Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Cash from Operations (2016 - 2025)

Macrogenics (MGNX) has disclosed Cash from Operations for 14 consecutive years, with 43021000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 212.01% to 43021000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 81040000.0, a 18.53% decrease, with the full-year FY2025 number at 81040000.0, down 18.53% from a year prior.
  • Cash from Operations was 43021000.0 for Q4 2025 at Macrogenics, up from 30186000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 60162000.0 in Q3 2024 to a low of 57696000.0 in Q1 2022.
  • A 5-year average of 22920350.0 and a median of 32716000.0 in 2023 define the central range for Cash from Operations.
  • Biggest YoY gain for Cash from Operations was 270.69% in 2024; the steepest drop was 2029.49% in 2024.
  • Macrogenics' Cash from Operations stood at 54309000.0 in 2021, then soared by 153.99% to 29320000.0 in 2022, then crashed by 195.62% to 28037000.0 in 2023, then plummeted by 36.99% to 38407000.0 in 2024, then surged by 212.01% to 43021000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Cash from Operations are 43021000.0 (Q4 2025), 30186000.0 (Q3 2025), and 46985000.0 (Q2 2025).